Your browser doesn't support javascript.
loading
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model.
Jespersen, Henrik; Lindberg, Mattias F; Donia, Marco; Söderberg, Elin M V; Andersen, Rikke; Keller, Ulrich; Ny, Lars; Svane, Inge Marie; Nilsson, Lisa M; Nilsson, Jonas A.
Afiliação
  • Jespersen H; From the Sahlgrenska Translational Melanoma Group, Institute of Clinical Science, Departments of Surgery and Oncology, Sahlgrenska Cancer Center at University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, 405 30, Sweden.
  • Lindberg MF; From the Sahlgrenska Translational Melanoma Group, Institute of Clinical Science, Departments of Surgery and Oncology, Sahlgrenska Cancer Center at University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, 405 30, Sweden.
  • Donia M; Center for Cancer Immune Therapy, Department of Hematology and Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, DK-2730, Denmark.
  • Söderberg EMV; From the Sahlgrenska Translational Melanoma Group, Institute of Clinical Science, Departments of Surgery and Oncology, Sahlgrenska Cancer Center at University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, 405 30, Sweden.
  • Andersen R; Center for Cancer Immune Therapy, Department of Hematology and Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, DK-2730, Denmark.
  • Keller U; Internal Medicine III, Technische Universität München, Munich, 81675, Germany.
  • Ny L; German Cancer Consortium/Deutsches Krebsforschungszentrum, Heidelberg, 69120, Germany.
  • Svane IM; From the Sahlgrenska Translational Melanoma Group, Institute of Clinical Science, Departments of Surgery and Oncology, Sahlgrenska Cancer Center at University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, 405 30, Sweden.
  • Nilsson LM; Center for Cancer Immune Therapy, Department of Hematology and Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, DK-2730, Denmark.
  • Nilsson JA; From the Sahlgrenska Translational Melanoma Group, Institute of Clinical Science, Departments of Surgery and Oncology, Sahlgrenska Cancer Center at University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, 405 30, Sweden.
Nat Commun ; 8(1): 707, 2017 09 27.
Article em En | MEDLINE | ID: mdl-28955032
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfócitos T / Linfócitos do Interstício Tumoral / Interleucina-2 / Melanoma Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfócitos T / Linfócitos do Interstício Tumoral / Interleucina-2 / Melanoma Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Suécia